264 related articles for article (PubMed ID: 28231003)
1. Utilization of Gastrointestinal Simulator, an in Vivo Predictive Dissolution Methodology, Coupled with Computational Approach To Forecast Oral Absorption of Dipyridamole.
Matsui K; Tsume Y; Takeuchi S; Searls A; Amidon GL
Mol Pharm; 2017 Apr; 14(4):1181-1189. PubMed ID: 28231003
[TBL] [Abstract][Full Text] [Related]
2. The impact of supersaturation level for oral absorption of BCS class IIb drugs, dipyridamole and ketoconazole, using in vivo predictive dissolution system: Gastrointestinal Simulator (GIS).
Tsume Y; Matsui K; Searls AL; Takeuchi S; Amidon GE; Sun D; Amidon GL
Eur J Pharm Sci; 2017 May; 102():126-139. PubMed ID: 28263914
[TBL] [Abstract][Full Text] [Related]
3. In Vitro Dissolution of Fluconazole and Dipyridamole in Gastrointestinal Simulator (GIS), Predicting in Vivo Dissolution and Drug-Drug Interaction Caused by Acid-Reducing Agents.
Matsui K; Tsume Y; Amidon GE; Amidon GL
Mol Pharm; 2015 Jul; 12(7):2418-28. PubMed ID: 25985298
[TBL] [Abstract][Full Text] [Related]
4. Integration of Precipitation Kinetics From an In Vitro, Multicompartment Transfer System and Mechanistic Oral Absorption Modeling for Pharmacokinetic Prediction of Weakly Basic Drugs.
Patel S; Zhu W; Xia B; Sharma N; Hermans A; Ehrick JD; Kesisoglou F; Pennington J
J Pharm Sci; 2019 Jan; 108(1):574-583. PubMed ID: 30395833
[TBL] [Abstract][Full Text] [Related]
5. Predicting the Changes in Oral Absorption of Weak Base Drugs Under Elevated Gastric pH Using an In Vitro-In Silico-In Vivo Approach: Case Examples-Dipyridamole, Prasugrel, and Nelfinavir.
Kambayashi A; Dressman JB
J Pharm Sci; 2019 Jan; 108(1):584-591. PubMed ID: 30423339
[TBL] [Abstract][Full Text] [Related]
6. In Silico Modeling Approach for the Evaluation of Gastrointestinal Dissolution, Supersaturation, and Precipitation of Posaconazole.
Hens B; Pathak SM; Mitra A; Patel N; Liu B; Patel S; Jamei M; Brouwers J; Augustijns P; Turner DB
Mol Pharm; 2017 Dec; 14(12):4321-4333. PubMed ID: 28817288
[TBL] [Abstract][Full Text] [Related]
7. In vitro dissolution methodology, mini-Gastrointestinal Simulator (mGIS), predicts better in vivo dissolution of a weak base drug, dasatinib.
Tsume Y; Takeuchi S; Matsui K; Amidon GE; Amidon GL
Eur J Pharm Sci; 2015 Aug; 76():203-12. PubMed ID: 25978875
[TBL] [Abstract][Full Text] [Related]
8. Effect of surfactants, gastric emptying, and dosage form on supersaturation of dipyridamole in an in vitro model simulating the stomach and duodenum.
Mitra A; Fadda HM
Mol Pharm; 2014 Aug; 11(8):2835-44. PubMed ID: 25025699
[TBL] [Abstract][Full Text] [Related]
9. Use of Gastrointestinal Simulator, Mass Transport Analysis, and Absorption Simulation to Investigate the Impact of pH Modifiers in Mitigating Weakly Basic Drugs' Performance Issues Related to Gastric pH: Palbociclib Case Study.
Kuminek G; Salehi N; Waltz NM; Sperry DC; Greenwood DE; Hate SS; Amidon GE
Mol Pharm; 2023 Jan; 20(1):147-158. PubMed ID: 36367432
[TBL] [Abstract][Full Text] [Related]
10. The Introduction of a New Flexible In Vivo Predictive Dissolution Apparatus, GIS-Alpha (GIS-α), to Study Dissolution Profiles of BCS Class IIb Drugs, Dipyridamole and Ketoconazole.
Tsume Y; Patel S; Wang M; Hermans A; Kesisoglou F
J Pharm Sci; 2020 Nov; 109(11):3471-3479. PubMed ID: 32888960
[TBL] [Abstract][Full Text] [Related]
11. The Evaluation of In Vitro Drug Dissolution of Commercially Available Oral Dosage Forms for Itraconazole in Gastrointestinal Simulator With Biorelevant Media.
Matsui K; Tsume Y; Amidon GE; Amidon GL
J Pharm Sci; 2016 Sep; 105(9):2804-2814. PubMed ID: 27020985
[TBL] [Abstract][Full Text] [Related]
12. Precipitation in the small intestine may play a more important role in the in vivo performance of poorly soluble weak bases in the fasted state: case example nelfinavir.
Shono Y; Jantratid E; Dressman JB
Eur J Pharm Biopharm; 2011 Oct; 79(2):349-56. PubMed ID: 21527341
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a three compartment in vitro gastrointestinal simulator dissolution apparatus to predict in vivo dissolution.
Takeuchi S; Tsume Y; Amidon GE; Amidon GL
J Pharm Sci; 2014 Nov; 103(11):3416-3422. PubMed ID: 25251982
[TBL] [Abstract][Full Text] [Related]
14. Forecasting in vivo oral absorption and food effect of micronized and nanosized aprepitant formulations in humans.
Shono Y; Jantratid E; Kesisoglou F; Reppas C; Dressman JB
Eur J Pharm Biopharm; 2010 Sep; 76(1):95-104. PubMed ID: 20576487
[TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal dissolution, supersaturation and precipitation of the weak base indinavir in healthy volunteers.
Rubbens J; Brouwers J; Tack J; Augustijns P
Eur J Pharm Biopharm; 2016 Dec; 109():122-129. PubMed ID: 27693678
[TBL] [Abstract][Full Text] [Related]
16. Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac.
Kambayashi A; Blume H; Dressman J
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1337-47. PubMed ID: 24056057
[TBL] [Abstract][Full Text] [Related]
17. Using a novel multicompartment dissolution system to predict the effect of gastric pH on the oral absorption of weak bases with poor intrinsic solubility.
Gu CH; Rao D; Gandhi RB; Hilden J; Raghavan K
J Pharm Sci; 2005 Jan; 94(1):199-208. PubMed ID: 15761943
[TBL] [Abstract][Full Text] [Related]
18. Prediction of oral absorption of cinnarizine--a highly supersaturating poorly soluble weak base with borderline permeability.
Berlin M; Przyklenk KH; Richtberg A; Baumann W; Dressman JB
Eur J Pharm Biopharm; 2014 Nov; 88(3):795-806. PubMed ID: 25195981
[TBL] [Abstract][Full Text] [Related]
19. pH-dependent dissolution in vitro and absorption in vivo of weakly basic drugs: development of a canine model.
Zhou R; Moench P; Heran C; Lu X; Mathias N; Faria TN; Wall DA; Hussain MA; Smith RL; Sun D
Pharm Res; 2005 Feb; 22(2):188-92. PubMed ID: 15783065
[TBL] [Abstract][Full Text] [Related]
20. Prediction of food effects on the absorption of celecoxib based on biorelevant dissolution testing coupled with physiologically based pharmacokinetic modeling.
Shono Y; Jantratid E; Janssen N; Kesisoglou F; Mao Y; Vertzoni M; Reppas C; Dressman JB
Eur J Pharm Biopharm; 2009 Sep; 73(1):107-14. PubMed ID: 19465123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
